Acadia Healthcar Financials
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Acadia Healthcar's revenue grew 7.7% year-over-year to $3.2B, a solid pace of expansion. This earns a growth score of 51/100.
Acadia Healthcar carries a low D/E ratio of 0.61, meaning only $0.61 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 88/100, indicating a strong balance sheet with room for future borrowing.
Acadia Healthcar's current ratio of 1.00 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 20/100, which could limit financial flexibility.
While Acadia Healthcar generated $129.7M in operating cash flow, capex of $690.4M consumed most of it, leaving -$560.7M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Acadia Healthcar's ROE of 8.3% shows moderate profitability relative to equity, earning a score of 33/100.
Acadia Healthcar passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Acadia Healthcar generates $0.51 in operating cash flow ($129.7M OCF vs $255.6M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
This page shows Acadia Healthcar (ACHC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Acadia Healthcar generated $3.2B in revenue in fiscal year 2024. This represents an increase of 7.7% from the prior year.
Acadia Healthcar generated -$560.7M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 1567.5% from the prior year.
Acadia Healthcar reported $255.6M in net income in fiscal year 2024. This represents an increase of 1279.7% from the prior year.
Acadia Healthcar earned $2.78 per diluted share (EPS) in fiscal year 2024. This represents an increase of 1258.3% from the prior year.
Acadia Healthcar held $76.3M in cash against $1.9B in long-term debt as of fiscal year 2024.
Acadia Healthcar had 92M shares outstanding in fiscal year 2024. This represents an increase of 0.6% from the prior year.
Acadia Healthcar's net profit margin was 8.1% in fiscal year 2024, showing the share of revenue converted to profit. This is up 8.8 percentage points from the prior year.
Acadia Healthcar's ROE was 8.3% in fiscal year 2024, measuring profit generated per dollar of shareholder equity.
Acadia Healthcar invested $690.4M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents an increase of 62.8% from the prior year.
ACHC Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $851.6M-2.0% | $869.2M+12.8% | $770.5M-0.5% | $774.2M-2.7% | $796.0M+3.6% | $768.1M+3.4% | $742.8M+1.6% | $731.3M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | -$36.6M-4.2% | -$35.1M-20.4% | -$29.2M+3.0% | -$30.1M-3.1% | -$29.2M-7.1% | -$27.2M-32.9% | -$20.5M+2.1% | -$20.9M |
| Income Tax | $1.7M-86.2% | $12.1M+174.0% | $4.4M-1.7% | $4.5M-82.5% | $25.6M+27.7% | $20.1M-0.7% | $20.2M-11.7% | $22.9M |
| Net Income | $36.2M+20.3% | $30.1M+259.8% | $8.4M-74.3% | $32.6M-58.4% | $78.5M+2.7% | $76.4M+32.3% | $57.7M-20.2% | $72.3M |
| EPS (Diluted) | $0.40+21.2% | $0.33+266.7% | $0.09-75.0% | $0.36-57.6% | $0.85+2.4% | $0.83+29.7% | $0.64-19.0% | $0.79 |
ACHC Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.4B+1.7% | $6.3B+2.6% | $6.1B+3.2% | $6.0B+4.9% | $5.7B+2.9% | $5.5B+3.0% | $5.4B+4.1% | $5.2B |
| Current Assets | $748.0M+8.2% | $691.6M+8.2% | $639.0M+10.6% | $577.5M-10.5% | $645.2M+5.6% | $610.8M+2.5% | $596.0M+3.0% | $578.8M |
| Cash & Equivalents | $118.7M-9.7% | $131.4M+44.0% | $91.2M+19.6% | $76.3M-1.1% | $77.2M-0.2% | $77.3M-22.8% | $100.1M-10.8% | $112.2M |
| Inventory | $6.2M+7.4% | $5.8M+1.9% | $5.7M+1.0% | $5.7M-5.6% | $6.0M+4.2% | $5.7M+8.4% | $5.3M-2.5% | $5.4M |
| Accounts Receivable | $430.8M+5.5% | $408.5M+3.0% | $396.6M+8.6% | $365.3M-6.2% | $389.4M+0.8% | $386.2M+6.8% | $361.5M+4.5% | $345.8M |
| Goodwill | $2.3B+0.4% | $2.3B0.0% | $2.3B+0.5% | $2.3B+0.2% | $2.3B0.0% | $2.3B+1.6% | $2.2B+0.1% | $2.2B |
| Total Liabilities | $3.1B+1.2% | $3.1B+3.7% | $3.0B+7.5% | $2.8B+5.8% | $2.6B+2.8% | $2.5B+2.9% | $2.5B+15.6% | $2.1B |
| Current Liabilities | $517.9M-1.1% | $523.7M+10.6% | $473.4M-18.1% | $577.9M+5.7% | $546.5M+13.3% | $482.3M-45.5% | $885.8M+104.8% | $432.5M |
| Long-Term Debt | $2.3B+1.7% | $2.2B+2.9% | $2.2B+16.2% | $1.9B+5.9% | $1.8B-1.1% | $1.8B+33.6% | $1.3B-2.2% | $1.4B |
| Total Equity | $3.1B+1.4% | $3.1B+1.2% | $3.0B-1.0% | $3.1B+4.1% | $3.0B+3.0% | $2.9B+3.0% | $2.8B-4.8% | $2.9B |
| Retained Earnings | $411.7M+9.7% | $375.4M+7.7% | $348.5M-10.0% | $387.3M+35.2% | $286.6M+37.7% | $208.1M+58.0% | $131.7M-54.8% | $291.7M |
ACHC Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $73.2M-45.2% | $133.5M+1063.2% | $11.5M-90.2% | $116.7M-31.8% | $171.1M+153.3% | -$321.3M-376.2% | $116.3M-29.0% | $163.8M |
| Capital Expenditures | $136.2M-18.8% | $167.7M-3.9% | $174.6M-14.2% | $203.5M+31.9% | $154.2M+8.3% | $142.4M+2.7% | $138.7M+52.7% | $90.8M |
| Free Cash Flow | -$63.0M-84.1% | -$34.2M+79.0% | -$163.2M-88.0% | -$86.8M-613.4% | $16.9M+103.6% | -$463.7M-1968.3% | -$22.4M-130.7% | $72.9M |
| Investing Cash Flow | -$129.8M+13.9% | -$150.8M+17.7% | -$183.2M+9.9% | -$203.3M-30.8% | -$155.5M+15.8% | -$184.6M-67.6% | -$110.2M-21.4% | -$90.8M |
| Financing Cash Flow | $43.8M-23.7% | $57.5M-69.2% | $186.7M+131.1% | $80.8M+611.3% | -$15.8M-103.3% | $483.1M+8644.9% | -$5.7M+77.1% | -$24.7M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $0-100.0% | $3.2M-93.3% | $46.9M | N/A | N/A | N/A | N/A | N/A |
ACHC Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | 4.3%+0.8pp | 3.5%+2.4pp | 1.1%-3.1pp | 4.2%-5.6pp | 9.9%-0.1pp | 10.0%+2.2pp | 7.8%-2.1pp | 9.9% |
| Return on Equity | 1.2%+0.2pp | 1.0%+0.7pp | 0.3%-0.8pp | 1.1%-1.6pp | 2.7%-0.0pp | 2.7%+0.6pp | 2.1%-0.4pp | 2.5% |
| Return on Assets | 0.6%+0.1pp | 0.5%+0.3pp | 0.1%-0.4pp | 0.5%-0.8pp | 1.4%0.0pp | 1.4%+0.3pp | 1.1%-0.3pp | 1.4% |
| Current Ratio | 1.44+0.1 | 1.32-0.0 | 1.35+0.4 | 1.00-0.2 | 1.18-0.1 | 1.27+0.6 | 0.67-0.7 | 1.34 |
| Debt-to-Equity | 0.730.0 | 0.73+0.0 | 0.72+0.1 | 0.61+0.0 | 0.60-0.0 | 0.63+0.1 | 0.48+0.0 | 0.47 |
| FCF Margin | -7.4%-3.5pp | -3.9%+17.2pp | -21.2%-10.0pp | -11.2%-13.3pp | 2.1%+62.5pp | -60.4%-57.4pp | -3.0%-13.0pp | 10.0% |
Note: The current ratio is below 1.0 (1.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Acadia Healthcar's annual revenue?
Acadia Healthcar (ACHC) reported $3.2B in total revenue for fiscal year 2024. This represents a 7.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Acadia Healthcar's revenue growing?
Acadia Healthcar (ACHC) revenue grew by 7.7% year-over-year, from $2.9B to $3.2B in fiscal year 2024.
Is Acadia Healthcar profitable?
Yes, Acadia Healthcar (ACHC) reported a net income of $255.6M in fiscal year 2024, with a net profit margin of 8.1%.
What is Acadia Healthcar's earnings per share (EPS)?
Acadia Healthcar (ACHC) reported diluted earnings per share of $2.78 for fiscal year 2024. This represents a 1258.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
How much debt does Acadia Healthcar have?
As of fiscal year 2024, Acadia Healthcar (ACHC) had $76.3M in cash and equivalents against $1.9B in long-term debt.
What is Acadia Healthcar's net profit margin?
Acadia Healthcar (ACHC) had a net profit margin of 8.1% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Acadia Healthcar's return on equity (ROE)?
Acadia Healthcar (ACHC) has a return on equity of 8.3% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Acadia Healthcar's free cash flow?
Acadia Healthcar (ACHC) generated -$560.7M in free cash flow during fiscal year 2024. This represents a -1567.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Acadia Healthcar's operating cash flow?
Acadia Healthcar (ACHC) generated $129.7M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Acadia Healthcar's total assets?
Acadia Healthcar (ACHC) had $6.0B in total assets as of fiscal year 2024, including both current and long-term assets.
What are Acadia Healthcar's capital expenditures?
Acadia Healthcar (ACHC) invested $690.4M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How many shares does Acadia Healthcar have outstanding?
Acadia Healthcar (ACHC) had 92M shares outstanding as of fiscal year 2024.
What is Acadia Healthcar's current ratio?
Acadia Healthcar (ACHC) had a current ratio of 1.00 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is Acadia Healthcar's debt-to-equity ratio?
Acadia Healthcar (ACHC) had a debt-to-equity ratio of 0.61 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Acadia Healthcar's return on assets (ROA)?
Acadia Healthcar (ACHC) had a return on assets of 4.3% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Acadia Healthcar's Piotroski F-Score?
Acadia Healthcar (ACHC) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Acadia Healthcar's earnings high quality?
Acadia Healthcar (ACHC) has an earnings quality ratio of 0.51x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Acadia Healthcar?
Acadia Healthcar (ACHC) scores 38 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.